LGCSX
Price
$18.51
Change
+$0.05 (+0.27%)
Updated
Jun 6 closing price
Net Assets
174.84M
WGIFX
Price
$68.75
Change
-$0.00 (-0.00%)
Updated
Jun 5 closing price
Net Assets
130.86B
Interact to see
Advertisement

LGCSX vs WGIFX

Header iconLGCSX vs WGIFX Comparison
Open Charts LGCSX vs WGIFXBanner chart's image
Lord Abbett Global Equity R4
Price$18.51
Change+$0.05 (+0.27%)
VolumeN/A
Net Assets174.84M
American Funds Capital World Gr&Inc F2
Price$68.75
Change-$0.00 (-0.00%)
VolumeN/A
Net Assets130.86B
LGCSX vs WGIFX Comparison Chart
Loading...
View a ticker or compare two or three
VS
LGCSX vs. WGIFX commentary
Jun 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LGCSX is a Buy and WGIFX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
WGIFX has more cash in the bank: 131B vs. LGCSX (175M). WGIFX pays higher dividends than LGCSX: WGIFX (1.75) vs LGCSX (0.37). LGCSX was incepted earlier than WGIFX: LGCSX (8 years) vs WGIFX (17 years). LGCSX (1.72) is less costly to investors than WGIFX (0.52). LGCSX is a more actively managed with annual turnover of: 41.00 vs. WGIFX (27.00). LGCSX has a lower initial minimum investment than WGIFX: LGCSX (0) vs WGIFX (250). LGCSX annual gain was more profitable for investors over the last year : 14.68 vs. WGIFX (6.40). LGCSX return over 5 years is better than : 59.79 vs. WGIFX (46.53).
LGCSXWGIFXLGCSX / WGIFX
Total Expense Ratio0.900.52173%
Annual Report Gross Expense Ratio1.720.52331%
Fund Existence8 years17 years-
Gain YTD10.0788.745115%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets175M131B0%
Annual Yield % from dividends0.371.7521%
Returns for 1 year14.686.40229%
Returns for 3 years48.6130.21161%
Returns for 5 years59.7946.53128%
Returns for 10 yearsN/A53.53-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PHAT8.924.22
+89.79%
Phathom Pharmaceuticals
CXDO5.700.19
+3.45%
Crexendo
OCTO1.350.02
+1.64%
Eightco Holdings Inc
SLVM53.820.59
+1.11%
Sylvamo Corp
DRS44.38-0.01
-0.03%
Leonardo DRS